Neurocea Competitors and Similar CompaniesClear all
Neurocea's competitors and similar companies include Rigel Pharmaceuticals, CerSci Therapeutics, Neopharm Boston and Terns Pharmaceuticals.
 Neurocea Neurocea is a biopharmaceutical company engaged in developing oral therapy for CNS (central nervous system) diseases. |  Rigel Pharmaceuticals Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases. |  CerSci Therapeutics CerSci Therapeutics is a biotechnology company focused on delivering a new generation of non-opioid medicines. |  Neopharm Boston Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization. |  Terns Pharmaceuticals Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases. | |
Founding Date | Founding Date 2012 | Founding Date 1996 | Founding Date 2015 | Founding Date 2007 | Founding Date 2017 |
Type | Type Private | Type Public | Type Subsidiary | Type Subsidiary | Type Public |
Tags | |||||
Locations | Locations US HQ | Locations South San Francisco, US HQ | Locations Dallas, US HQ | Locations Marlborough, US HQ | Locations Foster City, US HQ |
Employees | Employees 7 | Employees 1633% increase | Employees 7 | Employees 717% increase | Employees 59 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 256 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 580.9 m |
Financial | |||||
Net income | Net income N/A | Net income $367m (FY, 2025) | Net income N/A | Net income N/A | Net income ($96.2m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 130m | Total funding raised $ 5.7m | Total funding raised N/A | Total funding raised $ 30m |
For sources of this data, please see the company profile
View Company Profiles
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
163↑ 3% increase
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
View companyCerSci Therapeutics
HQ
Dallas, US
CerSci Therapeutics is a biotechnology company focused on delivering a new generation of non-opioid medicines.
View companyNeopharm Boston
HQ
Marlborough, US
Neopharm Boston (formerly Averica Discovery Services) is an analytical development contract research organization.
View companyTerns Pharmaceuticals
HQ
Foster City, US
Employees
59
Terns Pharmaceuticals is a biopharmaceutical company developing small-molecule single-agent and combination therapy for the treatment of non-alcoholic steatohepatitis and other chronic liver diseases.
View company